LUIS
CAMINAL MONTERO
Investigador/a
Hospital Universitario San Cecilio
Granada, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (10)
2023
-
Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?
International Journal of Molecular Sciences, Vol. 24, Núm. 17
2021
-
Author Correction: BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis (Scientific Reports, (2021), 11, 1, (11510), 10.1038/s41598-021-91055-z)
Scientific Reports
-
BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
Scientific Reports, Vol. 11, Núm. 1
-
Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis
Scientific Reports, Vol. 11, Núm. 1
2016
-
Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399
-
Off-label use of rituximab for systemic lupus erythematosus in Europe
Lupus Science and Medicine, Vol. 3, Núm. 1
2015
-
Registry of the Spanish network for systemic sclerosis: Survival, prognostic factors, and causes of death
Medicine (United States), Vol. 94, Núm. 43
2014
-
Influence of the IL17A locus in giant cell arteritis susceptibility
Annals of the Rheumatic Diseases, Vol. 73, Núm. 9, pp. 1742-1745
2011
-
Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label
Arthritis Research and Therapy, Vol. 13, Núm. 4
2010
-
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases
Clinical and Experimental Rheumatology, Vol. 28, Núm. 4, pp. 468-476